← Evidence map

ReviewIndian dermatology online journal

Which is the Ideal JAK Inhibitor for Alopecia Areata - Baricitinib, Tofacitinib, Ritlecitinib or Ifidancitinib - Revisiting the Immunomechanisms of the JAK Pathway.

Kabir Sardana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

21 papers cite it

2024
2025
2026
pooled itcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 37521227